[HTML][HTML] Inflammation in vein graft disease

MR De Vries, PHA Quax - Frontiers in cardiovascular medicine, 2018 - frontiersin.org
Frontiers in cardiovascular medicine, 2018frontiersin.org
Bypass surgery is one of the most frequently used strategies to revascularize tissues
downstream occlusive atherosclerotic lesions. For venous bypass surgery the great
saphenous vein is the most commonly used vessel. Unfortunately, graft efficacy is low due to
the development of vascular inflammation, intimal hyperplasia and accelerated
atherosclerosis. Moreover, failure of grafts leads to significant adverse outcomes and even
mortality. The last couple of decades not much has changed in the treatment of vein graft …
Bypass surgery is one of the most frequently used strategies to revascularize tissues downstream occlusive atherosclerotic lesions. For venous bypass surgery the great saphenous vein is the most commonly used vessel. Unfortunately, graft efficacy is low due to the development of vascular inflammation, intimal hyperplasia and accelerated atherosclerosis. Moreover, failure of grafts leads to significant adverse outcomes and even mortality. The last couple of decades not much has changed in the treatment of vein graft disease (VGD). However, insight is the cellular and molecular mechanisms of VGD has increased. In this review, we discuss the latest insights on VGD and the role of inflammation in this. We discuss vein graft pathophysiology including hemodynamic changes, the role of vessel wall constitutions and vascular remodeling. We show that profound systemic and local inflammatory responses, including inflammation of the perivascular fat, involve both the innate and adaptive immune system.
Frontiers